ELK3 and cancer: Regarding regulation of the immune responses or chemoresistance of TNBCs, studies report that ELK3 renders cancer cells resistant to NK cells and cisplatin (CDDP) chemotherapy by regulating mitochondrial dynamics [12, 29, 41].